Christoph Engel

Profile photo of Christoph EngelDr Christoph Engel, MD (PD Dr. med. habil.) is a physician by training and has been working in the field of biostatistics and particularly clinical epidemiology of Lynch syndrome, and hereditary breast and ovarian cancer for more than 20 years.

He is leader of the research group ‘Hereditary Tumour Diseases’ at the Institute for Medical Informatics, Statistics and Epidemiology (IMISE) at the University of Leipzig, Germany. With his group, he is responsible for the central registries of the “German Consortium for Familial Intestinal Cancer” and the “German Consortium for Hereditary Breast and Ovarian Cancer”. Both consortia are involved in many international collaborative studies, such as the PLSD, CIMBA, BCAC, IBCCS, and others.

His major research interests are dedicated to the characterisation of cancer risks and risk factors in hereditary cancer predisposition syndromes, and the development and clinical validation of risk-adapted surveillance strategies. Together with colleagues from the Netherlands and Finland he has conducted the first pooled data analysis on comparing different colonoscopy surveillance intervals in Lynch syndrome.